Gileadi U - Search Results

1

Induced Disruption of the Iron-Regulatory Hormone Hepcidin Inhibits Acute Inflammatory Hypoferraemia.

Armitage AE, Lim PJ, Frost JN, Pasricha SR, Soilleux EJ, Evans E, Morovat A, Santos A, Diaz R, Biggs D, Davies B, Gileadi U, Robbins PA, Lakhal-Littleton S, Drakesmith H. Armitage AE, et al. Among authors: gileadi u. J Innate Immun. 2016;8(5):517-28. doi: 10.1159/000447713. Epub 2016 Jul 16. J Innate Immun. 2016. PMID: 27423740 Free PMC article.

2

Hepcidin regulation by innate immune and infectious stimuli.

Armitage AE, Eddowes LA, Gileadi U, Cole S, Spottiswoode N, Selvakumar TA, Ho LP, Townsend AR, Drakesmith H. Armitage AE, et al. Among authors: gileadi u. Blood. 2011 Oct 13;118(15):4129-39. doi: 10.1182/blood-2011-04-351957. Epub 2011 Aug 26. Blood. 2011. PMID: 21873546 Free article.

3

Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection.

Frost JN, Tan TK, Abbas M, Wideman SK, Bonadonna M, Stoffel NU, Wray K, Kronsteiner B, Smits G, Campagna DR, Duarte TL, Lopes JM, Shah A, Armitage AE, Arezes J, Lim PJ, Preston AE, Ahern D, Teh M, Naylor C, Salio M, Gileadi U, Andrews SC, Dunachie SJ, Zimmermann MB, van der Klis FRM, Cerundolo V, Bannard O, Draper SJ, Townsend ARM, Galy B, Fleming MD, Lewis MC, Drakesmith H. Frost JN, et al. Among authors: gileadi u. Med. 2021 Feb 12;2(2):164-179.e12. doi: 10.1016/j.medj.2020.10.004. Med. 2021. PMID: 33665641 Free PMC article.

4

Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases.

Lippert AH, Paluch C, Gaglioni M, Vuong MT, McColl J, Jenkins E, Fellermeyer M, Clarke J, Sharma S, Moreira da Silva S, Akkaya B, Anzilotti C, Morgan SH, Jessup CF, Körbel M, Gileadi U, Leitner J, Knox R, Chirifu M, Huo J, Yu S, Ashman N, Lui Y, Wilkinson I, Attfield KE, Fugger L, Robertson NJ, Lynch CJ, Murray L, Steinberger P, Santos AM, Lee SF, Cornall RJ, Klenerman D, Davis SJ. Lippert AH, et al. Among authors: gileadi u. Immunity. 2024 Feb 13;57(2):256-270.e10. doi: 10.1016/j.immuni.2024.01.007. Immunity. 2024. PMID: 38354703 Free article.

5

Effect of epitope flanking residues on the presentation of N-terminal cytotoxic T lymphocyte epitopes.

Gileadi U, Gallimore A, Van der Bruggen P, Cerundolo V. Gileadi U, et al. Eur J Immunol. 1999 Jul;29(7):2213-22. doi: 10.1002/(SICI)1521-4141(199907)29:07<2213::AID-IMMU2213>3.0.CO;2-8. Eur J Immunol. 1999. PMID: 10427984 Free article.

6

Competition between CTL narrows the immune response induced by prime-boost vaccination protocols.

Palmowski MJ, Choi EM, Hermans IF, Gilbert SC, Chen JL, Gileadi U, Salio M, Van Pel A, Man S, Bonin E, Liljestrom P, Dunbar PR, Cerundolo V. Palmowski MJ, et al. Among authors: gileadi u. J Immunol. 2002 May 1;168(9):4391-8. doi: 10.4049/jimmunol.168.9.4391. J Immunol. 2002. PMID: 11970981

7

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V. Hermans IF, et al. Among authors: gileadi u. J Immunol. 2003 Nov 15;171(10):5140-7. doi: 10.4049/jimmunol.171.10.5140. J Immunol. 2003. PMID: 14607913

8

The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.

Hermans IF, Silk JD, Yang J, Palmowski MJ, Gileadi U, McCarthy C, Salio M, Ronchese F, Cerundolo V. Hermans IF, et al. Among authors: gileadi u. J Immunol Methods. 2004 Feb 1;285(1):25-40. doi: 10.1016/j.jim.2003.10.017. J Immunol Methods. 2004. PMID: 14871532

9

Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.

Silk JD, Hermans IF, Gileadi U, Chong TW, Shepherd D, Salio M, Mathew B, Schmidt RR, Lunt SJ, Williams KJ, Stratford IJ, Harris AL, Cerundolo V. Silk JD, et al. Among authors: gileadi u. J Clin Invest. 2004 Dec;114(12):1800-11. doi: 10.1172/JCI22046. J Clin Invest. 2004. PMID: 15599405 Free PMC article.

10

Role of immunoproteasomes in cross-presentation.

Palmowski MJ, Gileadi U, Salio M, Gallimore A, Millrain M, James E, Addey C, Scott D, Dyson J, Simpson E, Cerundolo V. Palmowski MJ, et al. Among authors: gileadi u. J Immunol. 2006 Jul 15;177(2):983-90. doi: 10.4049/jimmunol.177.2.983. J Immunol. 2006. PMID: 16818754

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page